Skip to main content
ALLERGY THERAPEUTICS PLC logo

ALLERGY THERAPEUTICS PLC — Investor Relations & Filings

Ticker · AGY ISIN · GB00B02LCQ05 LEI · 213800PQ7AHK7KGVOE23 IL Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2024-03-12 Regulatory Filings
Country GB United Kingdom
Listing IL AGY

About ALLERGY THERAPEUTICS PLC

https://allergytherapeutics.com/

Allergy Therapeutics PLC is an immunology company focused on the research, development, diagnosis, and treatment of allergic disorders. The company specializes in creating therapies for allergy treatment and prevention, with a key focus on developing aluminum-free immunotherapies and allergy vaccines. These treatments aim to address the underlying cause of the allergy rather than merely managing symptoms. Leveraging its specialist expertise in immunology, the company strives to develop effective and convenient solutions to improve the quality of life for individuals with allergies.

Recent filings

Filing Released Lang Actions
VLP Peanut PROTECT Trial Update
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and contains a date (12 March 2024) and company information, typical of a regulatory news service announcement. The content details the commencement of dosing in a clinical trial (Phase I/IIa VLP Peanut PROTECT Trial) and includes commentary from the CEO. This type of operational/clinical update, distributed via RNS, is a general regulatory announcement. Since it is not a full financial report (10-K, IR), a specific management change (MANG), or a dividend notice (DIV), and it is a direct announcement rather than a report publication announcement (RPA), the most appropriate general category is Regulatory Filings (RNS). The document length is moderate (5489 chars), but the structure strongly suggests a standard RNS release.
2024-03-12 English
Appointment of Shaun Furlong to Board of Directors
Board/Management Information Classification · 98% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service), indicated by the 'RNS Number' and the closing footer referencing RNS and the London Stock Exchange. The core content announces the 'Appointment of Dr. Shaun Furlong to Board of Directors' and details his new role as an Executive Director. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management. Although it is distributed via RNS, the specific subject matter is management change, making MANG the most precise classification over the general RNS fallback.
2024-03-11 English
Result of AGM
AGM Information Classification · 99% confidence The document explicitly states it is announcing the 'Result of Annual General Meeting' held on March 8, 2024. It details the results of all proposed resolutions (Ordinary and Special) via poll vote, including the 'For', 'Against', and 'Withheld' percentages. This content directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements'. Although it relates to an AGM, the core content is the voting outcome tabulation, making DVA more specific than AGM-R (which is for presentations/materials). The presence of the RNS Number and the LSE footer confirms it is a regulatory announcement, but DVA is the most precise category for voting results.
2024-03-08 English
Group of companies' accounts made up to 2023-06-30
Regulatory Filings
2024-03-07 English
Half-Year Trading Update 2024
Earnings Release Classification · 100% confidence The document is identified by the RNS Number header and the closing statement indicating it is provided by RNS, the news service of the London Stock Exchange. The content provides a 'Half-Year Trading Update 2024' for the six months ended 31 December 2023, detailing preliminary financial figures (revenue, cash balance) and updates on R&D pipelines (Grass MATA MPL, VLP Peanut). This is a pre-release of key financial highlights for an interim period, announced ahead of the full Half Year Results in March 2024. This fits the definition of an Earnings Release (ER), which covers initial announcements of periodical financial results (key highlights only). Although it covers a half-year period, it is explicitly a 'Trading Update' providing key figures, not the comprehensive 'Interim Report' (IR). Since it is a primary, time-sensitive financial announcement, ER is the most appropriate code. H1 2024
2024-02-14 English
Notice of 2023 Annual General Meeting
AGM Information Classification · 98% confidence The document explicitly states 'Notice of 2023 Annual General Meeting' and mentions that the notice has been published and posted to shareholders. This indicates an announcement related to the AGM. The document is short (3033 characters) and serves to inform the market about the publication of the AGM notice, rather than being the full AGM presentation or the proxy statement itself. Therefore, it fits best under AGM Information (AGM-R). Although it is an announcement, AGM-R is more specific than the general RPA or RNS for this context.
2024-02-09 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.